Role of herbal medicine for controlling coronavirus (SARS-CoV-2) disease (COVID-19)

Ravindra B. Malabadi, Neelambika T. Meti and Raju K. Chalannavar
Additional contact information
Ravindra B. Malabadi: Department of Applied Botany, Mangalore University, Mangalagangotri-574199, Mangalore, Karnataka State, India
Neelambika T. Meti: Plant Biotechnology Laboratory, Rajiv Gandhi Institute of IT and Biotechnology, Bharati Vidyapeeth University, Pune-Satara Road, Katraj, Pune – 411046, Maharashtra State, India
Raju K. Chalannavar: Department of Applied Botany, Mangalore University, Mangalagangotri-574199, Mangalore, Karnataka State, India

International Journal of Research and Scientific Innovation, 2021, vol. 8, issue 2, 135-165

Abstract: This review paper highlights the use of herbal medicine in the management of the coronavirus disease COVID-19 (SARS-CoV-2) pandemic, which has caused a worldwide outbreak of respiratory illness. This is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which is zoonotic infecting both animal and human. Vaccines are the most promising solution to mitigate new viral strains. The Indian system of holistic medicine known as “Ayurveda†plays an important role in controling the viral disease SARS-CoV-2 and other health disorders. Dietary therapy and herbal medicine could be a complementary preventive therapy for COVID-19 (SARS-CoV-2). Plants have been used as a expression systems for the production of diagnostic reagents and pharmaceutical proteins often described as ‘molecular farming. On the basis of literature survy presented, some of the plant secondary metabolites that showed prominent antiviral activity against coronaviruses SARS-CoV-2 through impeding the main machinery used in their pathogenesis and replication cycle. The in vitro, in vivo, and in silico investigations revealed numerous plant-derived compounds with promising anti- SARS-CoV and anti- SARS CoV-2 activity. Therefore, this review gathered all antiviral plants in a single platform to facilitate the laboratory-based research for the development of novel drug/molecular therapeutics to overcome the SARS-CoV-2 and future pandemic situations. Further detailed clinical trial experiments should be conducted for the scientific validation.

Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.rsisinternational.org/journals/ijrsi/d ... -issue-2/135-165.pdf (application/pdf)
https://www.rsisinternational.org/virtual-library/ ... -2-disease-covid-19/

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bjc:journl:v:8:y:2021:i:2:p:135-165

Access Statistics for this article

International Journal of Research and Scientific Innovation is currently edited by Dr. Renu Malsaria

More articles in International Journal of Research and Scientific Innovation from International Journal of Research and Scientific Innovation (IJRSI)
Bibliographic data for series maintained by Dr. Renu Malsaria ().